Insulin glargine and lixisenatide and Stahist AD
Determining the interaction of Insulin glargine and lixisenatide and Stahist AD and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: chlorcyclizine / pseudoephedrine
Brand name: NasOpen, Stahist AD
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Stahist AD (Chlorcyclizine and Pseudoephedrine Liquid)
- Insulin glargine and lixisenatide-Stahist AD (Chlorcyclizine and Pseudoephedrine Tablets)
- Insulin glargine and lixisenatide-Stalevo
- Insulin glargine and lixisenatide-Stalevo 100
- Insulin glargine and lixisenatide-Stalevo 125
- Insulin glargine and lixisenatide-Stalevo 150
- Stahist AD-Insulin glargine and lixisenatide Subcutaneous
- Stahist AD-Insulin glargine, recombinant Subcutaneous
- Stahist AD-Insulin glulisine
- Stahist AD-Insulin Glulisine (Cartridges and Pens)
- Stahist AD-Insulin Glulisine (Vials)
- Stahist AD-Insulin glulisine Subcutaneous